A Phase II Study of Binimetinib in Combination with Encorafenib in Adults with Recurrent BRAF V600-Mutated High-Grade Astrocytoma or other Primary Brain Tumor

Grant

Date/time Interval

  • February 24, 2020 - February 23, 2021
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4040.00
  • Sponsor Award Id

  • ABTC 1802
  • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Mina Lobbous   Investigator  
  • Xiaosi Han   Investigator